Global Wealth Management Investment Advisory’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-12
| Closed | -$9 | – | 474 |
|
|
2023
Q4 | $9 | Hold |
12
| – | – | ﹤0.01% | 474 |
|
|
2023
Q3 | $10 | Hold |
12
| – | – | ﹤0.01% | 476 |
|
|
2023
Q2 | $22 | Buy |
+12
| New | +$22 | ﹤0.01% | 483 |
|
|
2022
Q3 | – | Sell |
-13
| Closed | – | – | 516 |
|
|
2022
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 550 |
|
|
2022
Q1 | $0 | Hold |
13
| – | – | ﹤0.01% | 541 |
|
|
2021
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 444 |
|
|
2021
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 455 |
|
|
2021
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 426 |
|
|
2021
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 430 |
|
|
2020
Q4 | $2K | Hold |
13
| – | – | ﹤0.01% | 414 |
|
|
2020
Q3 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 404 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 705 |
|